磁共振弹性成像肝硬度与MEFIB指数在非酒精性脂肪性肝病中与肝脏相关结局的关联:个体参与者数据的系统综述与Meta分析
该个体参与者数据汇总Meta分析纳入6个队列共2018例非酒精性脂肪性肝病患者,评估磁共振弹性成像(MRE)肝硬度与肝脏相关结局的关联。中位随访3年,MRE 5-8 kPa和≥8 kPa者主要结局风险显著高于MRE<5 kPa者;MEFIB指数阳性与主要结局强关联,阴性预测值5年达99.1%。
要点
- MRE 5-8 kPa者主要结局风险为MRE<5 kPa者的11.0倍(HR 11.0,95%CI 7.03-17.1,P<.001),≥8 kPa者为15.9倍。
- MEFIB指数阳性者主要结局HR 20.6(95%CI 10.4-40.8,P<.001),阴性预测值5年99.1%。
- MRE≥8 kPa组3年肝细胞癌累积风险5.66%,5-8 kPa组5.25%,<5 kPa组0.35%。
核心结论
- MRE评估的肝硬度与肝脏相关事件相关,MRE联合Fibrosis-4对肝功能失代偿具有极好的阴性预测价值。
- 这些数据对临床实践有重要意义。
研究设计与样本
- 系统检索纳入6个成人非酒精性脂肪性肝病队列,基线接受MRE并随访肝功能失代偿、肝细胞癌和死亡。
- 采用Cox和logistic回归评估MRE肝硬度与肝脏相关结局的关联,主要复合结局包括需治疗的静脉曲张、腹水和肝性脑病。
主要发现
- 共纳入2018例患者(女性53%),平均年龄57.8(±14)岁,基线MRE平均4.15(±2.19)kPa。
- 有纵向数据的1707例患者中位随访3(四分位距4.2)年,与MRE<5 kPa者相比,MRE 5-8 kPa者主要结局HR 11.0(95%CI 7.03-17.1,P<.001),MRE≥8 kPa者HR 15.9(95%CI 9.32-27.2,P<.001)。
- MEFIB指数(MRE≥3.3 kPa且Fibrosis-4≥1.6为阳性)与主要结局强关联,HR 20.6(95%CI 10.4-40.8,P<.001),MEFIB阴性者5年主要结局阴性预测值99.1%。
- 3年肝细胞癌累积风险:MRE<5 kPa组0.35%,5-8 kPa组5.25%,≥8 kPa组5.66%。
临床怎么用
- 原文结论指出MRE肝硬度与肝脏相关事件相关,MRE联合Fibrosis-4对肝功能失代偿具有极好的阴性预测价值,这些数据对临床实践有重要意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Magnetic resonance elastography (MRE) is an accurate biomarker of liver fibrosis; however, limited data characterize its association with clinical outcomes. We conducted an individual participant data pooled meta-analysis on patients with nonalcoholic fatty liver disease to evaluate the association between liver stiffness on MRE and liver-related outcomes. METHODS: A systematic search identified 6 cohorts of adults with nonalcoholic fatty liver disease who underwent a baseline MRE and were followed for hepatic decompensation, hepatocellular carcinoma, and death. Cox and logistic regression were used to assess the association between liver stiffness on MRE and liver-related outcomes, including a composite primary outcome defined as varices needing treatment, ascites, and hepatic encephalopathy. RESULTS: This individual participant data pooled meta-analysis included 2018 patients (53% women) with a mean (± standard deviation) age of 57.8 (±14) years and MRE at baseline of 4.15 (±2.19) kPa, respectively. Among 1707 patients with available longitudinal data with a median (interquartile range) of 3 (4.2) years of follow-up, the hazard ratio for the primary outcome for MRE of 5 to 8 kPa was 11.0 (95% confidence interval [CI]: 7.03-17.1, P < .001) and for ≥ 8 kPa was 15.9 (95% CI: 9.32-27.2, P < .001), compared with those with MRE <5 kPa. The MEFIB index (defined as positive when MRE ≥3.3 kPa and Fibrosis-4 ≥1.6) had a robust association with the primary outcome with a hazard ratio of 20.6 (95% CI: 10.4-40.8, P < .001) and a negative MEFIB had a high negative predictive value for the primary outcome, 99.1% at 5 years. The 3-year risk of incident hepatocellular carcinoma was 0.35% for MRE <5 kPa, 5.25% for 5 to 8 kPa, and 5.66% for MRE ≥8 kPa, respectively. CONCLUSION: Liver stiffness assessed by MRE is associated with liver-related events, and the combination of MRE and Fibrosis-4 has excellent negative predictive value for hepatic decompensation. These data have important implications for clinical practice.
引用
- Ajmera V, Kim BK, Yang K, et al. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants. Gastroenterology. 2022. PMID: 35788349. doi:10.1053/j.gastro.2022.06.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。